Clinical Trials List
2016-12-13 - 2022-05-05
Phase III
Terminated3
ICD-10C91.10
Chronic lymphocytic leukemia of B-cell type not having achieved remission
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Tzu-Ting Chen Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Li-Yuan Bai Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jyh-Pyng Gau Division of Hematology & Oncology
- Po-Shen Ko Division of Hematology & Oncology
- San-Chi Chen Division of Hematology & Oncology
- Yao-Chung Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- - - Division of Hematology & Oncology
- 林建廷 Division of General Internal Medicine
- - - Division of Hematology & Oncology
- Tai-Chung Huang Division of Hematology & Oncology
- CHENG-HONG TSAI Division of Hematology & Oncology
- Wen-Chien Chou Division of Others -
- MING YAO Division of Hematology & Oncology
- 陳尹愷 Division of General Internal Medicine
- 劉高郎 Division of Radiology
- 田豐銘 Division of Hematology & Oncology
- Chien-Chin Lin Division of Others -
- Jih-Luh Tang Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
- Chieh-Lung Cheng Division of Hematology & Oncology
- HSIN-AN HOU Division of Hematology & Oncology
- 徐思淳 Division of Others
- 劉家豪 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
210 participants
